Skip to main content
. Author manuscript; available in PMC: 2013 Jan 1.
Published in final edited form as: Drug Alcohol Depend. 2011 Aug 15;120(1-3):229–232. doi: 10.1016/j.drugalcdep.2011.07.006

Table 1.

Mean peak, trough, or average scores/ratings (±SEM) of subjective, psychomotor, and physiological effects significantly affected by one or more of the active drug conditions.

P value Placebo CARIS 350 OXY 10 CARIS 350/OXY 10
Subjective effects measures
ARCI
BGa,b (range: 0–13) <0.001 4.5 (0.6) 3.5 (0.5) 2.6 (0.5)* 2.0 (0.6)*
LSDb (range: 0–14) <0.001 4.2 (0.6) 4.2 (0.5) 6.4 (0.8)* 5.8 (0.7)*
PCAGb (range: 0–15) <0.001 5.8 (0.9) 7.1 (0.9) 9.3 (0.8)* 9.4 (0.7)*
Adjective rating scale (range: 0–4)
Dry mouth 0.003 0.4 (0.2) 0.4 (0.2) 1.3 (0.3)* 0.9 (0.3)
Flushing 0.002 0.1 (0.1) 0.1 (0.1) 0.9 (0.3)* 0.5 (0.2)
Nodding 0.005 0.1 (0.1) 0.9 (0.3) 1.2 (0.4) 1.7 (0.4)*
Numb 0.004 0.2 (0.1) 0.1 (0.1) 0.5 (0.2) 0.9 (0.3)*
Skin itchy <0.001 0 (0) 0.1 (0.1) 0.8 (0.2)* 1.3 (0.3)*
VAS (range: 0–100)
Coasting (‘spaced out’) <0.001 15.3 (7.4) 13.3 (5.9) 28.5 (8.6) 43.7 (9.8)*
Difficulty concentrating 0.003 19.2 (7.7) 26.5 (8.4) 39.3 (10.5) 48.5 (10.2)*
Dizzy 0.01 7.3 (5.8) 7.5 (6.1) 22.6 (9.1)* 18.7 (7.1)
Dreamy <0.001 16.7 (7.9) 16.0 (6.8) 25.0 (7.8) 43.9 (9.9)*
Floating <0.001 7.4 (5.4) 2.3 (1.1) 19.3 (7.8) 34.5 (9.2)*
Heavy, sluggish feeling 0.009 19.5 (9.2) 26.5 (8.4) 37.7 (10.1) 48.5 (10.3)*
High (drug ‘high’) <0.001 4.7 (4.0) 8.5 (6.1) 25.2 (8.1)* 36.9 (10.2)*
Lightheaded 0.004 4.3 (1.9) 2.3 (1.0) 26.1 (8.5)* 25.7 (8.4)*
Pleasant bodily sensations 0.004 6.8 (4.5) 6.7 (4.9) 18.1 (5.7) 23.7 (8.4)*
Pleasant thoughts 0.009 20.1 (7.8) 25.1 (6.8) 48.5 (10.6)* 30.9 (7.7)
Sedated (calm, tranquil) 0.007 14.8 (6.3) 21.9 (6.2) 35.1 (7.6)* 33.9 (8.0)*
Unpleasant bodily sensations 0.01 10.0 (6.4) 9.9 (6.8) 22.5 (8.9)* 16.7 (8.0)
Drug effect/Drug liking/Take againc
Feel drug effect <0.001 2.0 (0.2) 2.5 (0.2) 3.7 (0.2)* 3.8 (0.2)*
Like drug 0.02 58.1 (4.0) 58.1 (2.8) 66.4 (6.4) 72.2 (5.4)*
Like druga 0.006 47.2 (0.7) 44.1 (1.5) 34.7 (5.3)* 33.7 (4.6)*
Take drug again 0.03 60.3 (4.3) 61.3 (3.6) 68.0 (6.3) 74.9 (5.4)*
Take drug againa 0.01 53.1 (3.0) 45.1 (2.1) 37.1 (6.0)* 36.1 (4.6)*
Post-session Sequelae Questionnaire (Range: 0–4)
Nausea 0.004 0.1 (0.1) 0 (0) 0.6 (0.3) 0.9 (0.3)*
Psychomotor measures
ART (msec)b 0.01 332 (12) 343 (14) 343 (17) 369 (18)*
DSST (# of symbols completed)a 0.02 45.6 (2.0) 41.9 (3.2) 41.3 (2.6) 37.6 (2.3)*
DSST (# of symbols correct)a 0.01 45.3 (2.1) 41.1 (3.3) 41.1 (2.6) 37.1 (2.4)*
LRT (# of statements completed)a,b,d 0.008 17.8 (1.4) 15.9 (1.2) 15.6 (1.2) 14.4 (1.2)*
LRT (# of statements correct)a,b,d 0.009 15.6 (1.9) 13.4 (1.4) 13.2 (1.6) 11.9 (1.5)*
Physiological measures
Miosis (mm)a <0.001 6.6 (0.3) 6.5 (0.3) 4.9 (0.4)* 4.4 (0.4)*

Abbreviations: CARIS 350, carisoprodol 350 mg; OXY 10, oxycodone 10 mg; CARIS 350/OXY 10, carisoprodol followed 60 min later by 10 mg oxycodone; ARCI, Addiction Research Center Inventory; BG, Benzedrine Group scale; LSD, Lysergic Acid Diethylamide scale; PCAG, Pentobarbital-Chlorpromazine-Alcohol Group scale; ART, auditory reaction time; DSST, Digit Symbol Substitution Test; EHC, eye-hand coordination test; LRT, logical reasoning test

*

p<0.05 compared with placebo

a

trough rating

b

data based on 14 subjects – one subject’s data not included because of missing data due to a file transfer error

c

Drug effect, range 1–5 in which 1=I feel no effect at all from the drug(s) and 5=I feel a very strong effect; Like drug, range, 0–100, 0=dislike a lot, 50=neutral, 100=like a lot; Take again, 0=definitely would not, 50=neutral (don’t care), 100=definitely would. Last measure refers to desire to take drug(s) again on another session if given the opportunity

d

the LRT is a 1-min computerized test that consists of true-false statements about the juxtaposition of the two letters A and B (e.g., A is preceded by B – true or false)